// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























7277 Abstracts

Anti‐TFPI antibody bay 1093884: Early termination of phase II dose escalation study due to thrombosis

F. Ferrante - European Association for Haemophilia and Allied Disorders (EAHAD) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Adherence of hemophilia patients with prophylaxis: veritas‐pro and psychometric properties adapted to Turkish

Z. Demirci - European Association for Haemophilia and Allied Disorders (EAHAD) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Acquired factor V inhibitors: A case report

C. Ambaglio - European Association for Haemophilia and Allied Disorders (EAHAD) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Methylprednisolone

Comparison of low molecular‐weight and low dose unfractionated heparin for the prophylaxis of venous thromboembolism in spinal cord injury patients: A meta‐analysis using real‐world evidence

M. S. Hussain - European Association for Haemophilia and Allied Disorders (EAHAD) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Heparin

Audit of factor XI concentrate use in the United Kingdom – A single centre experience

Y. Tan - European Association for Haemophilia and Allied Disorders (EAHAD) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Correlation among joint health and health‐related quality of life in adult patients with hemophilia: A pilot study

S. nal Aykar - European Association for Haemophilia and Allied Disorders (EAHAD) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Comparison of balance and functional mobility between overweight and normal‐weight adult patients with hemophilia

S. nal Aykar - European Association for Haemophilia and Allied Disorders (EAHAD) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Bleeding disorders within the family

N. Uitslager - European Association for Haemophilia and Allied Disorders (EAHAD) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Future diagnostics of platelet disorders

K. Freson - European Association for Haemophilia and Allied Disorders (EAHAD) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Methadone hydrochloride

RISK FACTORS FOR THROMBOEMBOLISM IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Ana Boban - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

EARLY DEATHS IN ACUTE PROMYELOCYTIC LEUKEMIA: ANALYSIS OF PREDICTIVE FACTORS IN OUR INSTITUTION IN THE LAST 20 YEARS

Jose Maria Raya - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Arsenic trioxide

VENOUS THROMBOSIS AND BASELINE C-REACTIVE PROTEIN ARE INDEPENDENT PROGNOSTIC MARKERS IN DIFFUSE LARGE B-CELL LYMPHOMA AND IDENTIFY A GROUP OF PATIENTS WITH SIGNIFICANTLY INFERIOR OUTCOMES

Mark Grech - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Rituximab

HEMOPHILIA ASSOCIATED BONE PATHOLOGY IMPACTS QUALITY OF LIFE

Galen Goldscheitter - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

FVIII

PATIENTS WITH HIGHER BODY MASS INDEX TREATED WITH DIRECT / NON VITAMIN K DEPENDENT ANTICOAGULANTS (DOAC / NOAC) EXPERIENCE WORSE CLINICAL OUTCOMES

Marko Lucijanic - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

rivaroxaban

THE ROLE OF WHOLE-BODY MAGNETIC RESONANCE IMAGING IN THE DETECTION OF VASCULAR EVENTS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.

Begoa Navarro-Almenzar - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Eculizumab

THREE CHRONIC MYELOID LEUKEMIA CASES THAT PRESENTED LIKE ESSENTIAL THROMBOCYTHEMIA

Vedat Aslan - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Hydroxyurea

SAFETY AND UTILIZATION OF MIDLINE CATHETERS VERSUS TUNNELED CENTRAL VENOUS CATHETERS IN THE MANAGEMENT OF ACUTE MYELOID LEUKEMIA PATIENTS: A SINGLE CENTER EXPERIENCE.

Hlne Gardeney - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Hydroxyzine

Temporal Trends in Incidence, Prevalence and Epidemiological Characteristics of Cerebral Venous Thrombosis in the United States

Fadar Otite - International Stroke Conference (ISC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Thromboembolism in Atrial Fibrillation

Glen C Jickling - International Stroke Conference (ISC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Outcomes of the Stroke Thromboembolism Registry of Imaging and Pathology

Waleed Brinjikji - International Stroke Conference (ISC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Copyright © 2026. QuantiNova All rights reserved